Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory study

作者：Yongfeng Yu, Qisen Guo, Yongchang Zhang, Jian Fang, Diansheng Zhong, Baogang Liu, Pinhua Pan, Dongqing Lv, Lin Wu, Yanqiu Zhao, Juan Li, Zhihua Liu, Chunling Liu, Haichuan Su, Yun Fan, Tongmei Zhang, Anwen Liu, Bo Jin, Ye Wang, Jianying Zhou, Zhihong Zhang, Fengming Ran, Xia Song, Michael M. Shi, Weiguo Su, Shun Lu, Shun Lu, Yongfeng Yu, Qisen Guo, Yongchang Zhang, Jian Fang, Diansheng Zhong, Baogang Liu, Pinhua Pan, Dongqing Lv, Lin Wu, Yanqiu Zhao, Juan Li, Zhihua Liu, Chunling Liu, Haichuan Su, Yun Fan, Tongmei Zhang, Anwen Liu, Bo Jin, Ye Wang, Jianying Zhou, Zhihong Zhang, Fengming Ran, Xia Song, Mengzhao Wang, Xiaodong Zhang, Rui Ma, Zizheng Song, Xingya Li, Ying Cheng, Changli Wang, Liang Han, Jianhua Shi, Zhuang Yu, Yuan Chen, Jianan Huang, Xuhong Min, Limin Wang, Kaihua Lu, Minglei Yang, Pingli Wang, Xiaorong Dong, Guohua Yu, Buhai Wang, Jianhua Chang, Jianchun Duan, Shundong Cang, Quanyi Song, Jie Yu, Songhua Fan, Linfang Wang, Yongxin Ren, Xian Luo, Michael Shi, Weiguo Su, Shun Lu, Shun Lu · 发表于：The Lancet Respiratory Medicine · 年份：2024 · DOI：10.1016/s2213-2600(24)00211-x · 被引用次数：26 · 研究领域：Lung Cancer Treatments and Mutations、Lung Cancer Research Studies、Fibroblast Growth Factor Research